Vimarsana
Biggest News Aggregation in the World

Page 22 - Evoke Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evoke Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evoke Pharma Today - Breaking & Trending Today

Earnings Scheduled For May 12, 2021 - Vimarsana News

Earnings Scheduled For May 12, 2021

• PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report quarterly earnings at $1.01 per share on revenue of $570.79 million. • Zealand Pharma (NASDAQ:ZEAL) is likely to report quarterly loss at $1.01 per share on revenue of $9.89 million. • American Well (NYSE:AMWL) is likely to report quarterly loss at $0.19 per share on revenue of $58.75 million. • Crescent Point Energy (NYSE:CPG) is projected to report quarterly earnings at $0.03 per share on revenue of $492.10 million. • TORM (NASDAQ:TRMD) is expected to re...

Incretin-Based Drugs Market SWOT Analysis, Review Report Based on Current and Future Trends, Develop - Vimarsana News

Incretin-Based Drugs Market SWOT Analysis, Review Report Based on Current and Future Trends, Develop

Search jobs 28-Apr-2021 Incretin-Based Drugs Market SWOT Analysis, Review Report Based on Current and Future Trends, Developments and Opportunities 2021-2027 “On Incretin-Based Drugs Market, Market Research Store published a report overview By Size, Industry leading Manufactures, Trends, Industry Growth Analysis & Forecast Till 2026” includes 190+ research pages PDF with TOC come up with a list of figures and tables. Market Research Store presents an latest and updated Study on Incretin-Based Drugs Market 2021-2026. The report offers market p...

Evoke Pharma Reports Fourth Quarter and Full Year 2020 Financial Results - Vimarsana News

Evoke Pharma Reports Fourth Quarter and Full Year 2020 Financial Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evoke Pharma Reports Fourth Quarter and Full Year 2020 Financial Results Evoke Pharma, Inc.March 11, 2021 GMT SOLANA BEACH, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter ended December 31, 2020 and recent corporate developments. “Despite the challenges precipitated by the COVID-19 pandemic, 2020 proved t...

Source: apnews.com
Evoke Pharma, Inc. to Host Earnings Call - Vimarsana News

Evoke Pharma, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 11, 2021 / Evoke Pharma, Inc. (NASDAQ:EVOK) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 11, 2021 at 4:30 PM Eastern Time.

Source: yahoo.com
Gastroparesis Treatment Market to Exceed $5,323.62 Mn Worth by 2023: MRFR - Vimarsana News

Gastroparesis Treatment Market to Exceed $5,323.62 Mn Worth by 2023: MRFR

Gastroparesis Treatment Market to Exceed $5,323.62 Mn Worth by 2023: MRFR